[go: up one dir, main page]

JPH09501682A - プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物 - Google Patents

プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物

Info

Publication number
JPH09501682A
JPH09501682A JP7507271A JP50727195A JPH09501682A JP H09501682 A JPH09501682 A JP H09501682A JP 7507271 A JP7507271 A JP 7507271A JP 50727195 A JP50727195 A JP 50727195A JP H09501682 A JPH09501682 A JP H09501682A
Authority
JP
Japan
Prior art keywords
starch
progesterone
pharmaceutical composition
cellulose
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7507271A
Other languages
English (en)
Japanese (ja)
Inventor
スザンヌ グラム，カレン
イェンセン，アンネリセ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of JPH09501682A publication Critical patent/JPH09501682A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP7507271A 1993-08-20 1994-08-19 プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物 Pending JPH09501682A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
DK0950/93 1993-08-20
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (1)

Publication Number Publication Date
JPH09501682A true JPH09501682A (ja) 1997-02-18

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7507271A Pending JPH09501682A (ja) 1993-08-20 1994-08-19 プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物

Country Status (17)

Country Link
EP (1) EP0789560A1 (da)
JP (1) JPH09501682A (da)
KR (1) KR960703570A (da)
CN (1) CN1132478A (da)
AU (1) AU7530594A (da)
BR (1) BR9407306A (da)
CA (1) CA2169840A1 (da)
CZ (1) CZ42596A3 (da)
DK (1) DK95093D0 (da)
FI (1) FI960749A0 (da)
HU (1) HUT74167A (da)
LT (1) LT4043B (da)
NO (1) NO960653D0 (da)
NZ (1) NZ271617A (da)
PL (1) PL313113A1 (da)
SK (1) SK19396A3 (da)
WO (1) WO1995005807A1 (da)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009143959A (ja) * 1999-08-31 2009-07-02 Bayer Schering Pharma Ag 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤
JP2011026335A (ja) * 1998-11-18 2011-02-10 Ferring Bv プロゲステロン含有経膣投与用錠剤およびその調製法
JP2014521721A (ja) * 2011-08-05 2014-08-28 リポカイン インコーポレーテッド プロゲステロン含有の経口剤形及び関連する方法
JP2018024685A (ja) * 2011-11-23 2018-02-15 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
WO2003077923A1 (en) * 2002-03-14 2003-09-25 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
BRPI0409860A (pt) * 2003-04-29 2006-05-16 Akzo Nobel Nv processo de solidificação anti-solvente
CN101166521A (zh) 2005-04-28 2008-04-23 惠氏公司 通过湿制粒法制备包含微粒化他那普戈特的组合物
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011026335A (ja) * 1998-11-18 2011-02-10 Ferring Bv プロゲステロン含有経膣投与用錠剤およびその調製法
JP2009143959A (ja) * 1999-08-31 2009-07-02 Bayer Schering Pharma Ag 避妊薬として使用するためのエチニルエストラジオールとドロスピレノンとの組合せ剤
JP2014521721A (ja) * 2011-08-05 2014-08-28 リポカイン インコーポレーテッド プロゲステロン含有の経口剤形及び関連する方法
JP2018024685A (ja) * 2011-11-23 2018-02-15 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法

Also Published As

Publication number Publication date
PL313113A1 (en) 1996-06-10
WO1995005807A1 (en) 1995-03-02
AU7530594A (en) 1995-03-21
DK95093D0 (da) 1993-08-20
CZ42596A3 (en) 1996-06-12
SK19396A3 (en) 1997-03-05
NZ271617A (en) 1996-11-26
KR960703570A (ko) 1996-08-31
CA2169840A1 (en) 1995-03-02
LT96010A (da) 1996-06-25
NO960653L (no) 1996-02-19
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
CN1132478A (zh) 1996-10-02
LT4043B (en) 1996-09-25
BR9407306A (pt) 1996-10-08
NO960653D0 (no) 1996-02-19
EP0789560A1 (en) 1997-08-20
FI960749L (fi) 1996-02-19
FI960749A0 (fi) 1996-02-19

Similar Documents

Publication Publication Date Title
JPH09501682A (ja) プロゲステロンおよびポリエチレングリコール並びに賦形剤を含んでなる経口投与用新規医薬組成物
AU2022283615B2 (en) Orodispersible dosage unit containing an estetrol component
TWI508730B (zh) 含四氫葉酸之醫藥組合物
KR102539030B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
CZ296387B6 (cs) Antikoncepcní prípravek
CN107810001A (zh) 含雌四醇的口腔分散片剂
CN107750157A (zh) 含雌四醇的口腔分散片剂
JP2013166753A (ja) プロゲストゲン及び／又はエストロゲン及び５−メチル−（６ｓ）−テトラヒドロフォレートを含んで成る医薬組成物
MXPA04006057A (es) Productos farmaceuticos orales que contienen 3-alcanoato inferior de 17-beta-estradiol, metodo para administrar los mismos y proceso de preparacion.
JP2000502108A (ja) ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット
CN107771075A (zh) 含雌四醇组分的口腔分散剂量单位
ZA200100743B (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
RU2261106C2 (ru) Гормональная композиция на основе гестагена и эстрогена и ее применение
JP5060005B2 (ja) トリメゲストンを含む医薬組成物
JP2002509524A (ja) エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物
JP2942560B2 (ja) エストロゲン欠乏症治療用組成物
RU2258512C2 (ru) Противозачаточное лекарственное средство на основе гестагена и эстрогена и способ его получения
RU2215540C2 (ru) Схемы приема гестаген-антигестагена
TW200306846A (en) Hormone replacement therapy
MXPA01010976A (es) Uso de antiprogestagenos en terapia combinada.
TW200936142A (en) Use of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/carriers, for lactose-free oral contraception